RNS Number : 3763D
GenIP PLC
15 October 2025
15 October 2025
GenIP Plc
("GenIP" or the "Company")
Technology Park Alliance
GenIP Plc, a technology consultancy providing Generative Artificial Intelligence (GenAI) services to help research organisations and corporations commercialise their innovations, is pleased to announce a new collaboration with Pelotas Science Park (Parque Tecnológico de Pelotas) in Brazil, marking our first engagement with a technology park.
Pelotas Science Park serves as an innovation hub integrating the "quadruple helix": government, academia, industry, and civil society, and brings together incubators, coworking space, a regional startup network (Candy Valley), 63 resident and non-resident enterprises, and 23 partner institutions.
Under this partnership, GenIP will provide its suite of services to many of the park's tenant companies and incubated startups, guiding their decision-making process on which technologies are most viable for investment and commercialisation.
This agreement represents GenIP's efforts to lay the foundations for future growth through strategic alliances and partnerships, and aligns with the Company's strategic goal to diversify its client base beyond research organisations in order to increase the proportion of corporate clients to 45% of total clients.
Melissa Cruz, CEO of GenIP, commented:
"Our collaboration with Pelotas Science Park represents an important milestone for GenIP as we expand our reach beyond universities to support entire innovation ecosystems. Science parks play a vital role in Technology Transfer by connecting researchers, startups, and industry partners, and we're proud to provide the analytical foundation that helps their tenant companies identify commercially viable technologies and attract investment. This partnership reflects our broader strategy to deepen engagement with industry and startup communities, bringing us closer to our goal of achieving 45% industry participation."
Vinicius Farías Campos, President at Pelotas Technology Park, commented:
"Through its Health and Biotechnology Innovation Hub, the Pelotas Technology Park is proud to collaborate with GenIP in applying AI-driven methodologies for technology assessment and valorization. This partnership accelerates the translation of scientific research into real-world applications, strengthening Southern Brazil's innovation ecosystem in health and biotechnology."
For further information regarding GenIP, please visit www.genip.ai, or contact:
GenIP Plc Melissa Cruz, CEO
Via Redchurch Communications
AlbR Capital Limited (Broker) Colin Rowbury Jon Belliss
Redchurch Communications (Financial PR) John Casey
genip@weareredchurch.com
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
Notes to Editors
About GenIP
GenIP is a next-generation consultancy at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.
Service Offerings
GenIP operates through two synergistic service lines:
Service
Description
Value Proposition
Invention Intelligence Product Suite
AI-powered market intelligence reports assessing the commercial potential of emerging technologies
Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy
Talent and Executive Search Services
Executive search platform using machine learning and NLP to match innovation-driven organisations with commercialisation-ready leadership
De-risks scaling by aligning technical vision with proven executive capability
Together, these services form a unified GenAI-enabled platform for innovation triage and execution.
Vision & Strategy
GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:
● Organic Expansion
Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.
● Service Deepening
Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.
● Strategic Acquisitions
Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.
Forward looking statements
Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.
Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".
For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.
-ENDS-
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAFFSFALEISELS
